Humira (adalimumab) Disease area(s): Immunology Manufacturer(s): AbbVie 2024 Sales (USD): $8.99 billion Why it sold so well: In 2024, Humira remained a significant revenue contributor for AbbVie, despite facing substantial declines due to biosimilar competition following its US loss of exclusivity in January 2023
References 6
Xu H, Perez-Cuevas R, Xiong X, Reyes H, Roy C, Julien P, Smith G, von Dadelszen P, Leduc L, Audibert F, et al: An international trial of antioxidants in the prevention of preeclampsia (INTAPP)
GLP-1 Multi-District Litigation | Updates And What You Need To Know Jun 28, 2025 4 min read The wave of lawsuits involving GLP-1 receptor agonistssuch as Ozempic, Wegovy, Trulicity, and Mounjarohas evolved into one of the most closely watched mass torts in the country
A previous study showed that baicalein could decrease the yield of thiobarbituric acid, oxygen consumption rate, and iron reduction rate in the reaction system of ascorbic acid and FeCl 3 , and it showed a similar effect with iron chelators
